M&G Alternatives Investment Management Ltd 13D and 13G filings for Barinthus Biotherapeutics plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-01-19 08:27 am Unchanged | 2022-01-19 | 13G | Barinthus Biotherapeutics plc BRNS | M&G Alternatives Investment Management Ltd | 4,108,752 11.970% | 0 (Unchanged) | Filing |
2021-11-05 1:33 pm Purchase | 2021-04-29 | 13G | Barinthus Biotherapeutics plc BRNS | M&G Alternatives Investment Management Ltd | 4,108,752 11.970% | 4,108,752![]() (New Position) | Filing |